KR920016088A - 하부 요로 질환의 치료 - Google Patents

하부 요로 질환의 치료 Download PDF

Info

Publication number
KR920016088A
KR920016088A KR1019920002706A KR920002706A KR920016088A KR 920016088 A KR920016088 A KR 920016088A KR 1019920002706 A KR1019920002706 A KR 1019920002706A KR 920002706 A KR920002706 A KR 920002706A KR 920016088 A KR920016088 A KR 920016088A
Authority
KR
South Korea
Prior art keywords
treatment
urinary tract
lower urinary
tomoxetine
pharmaceutically acceptable
Prior art date
Application number
KR1019920002706A
Other languages
English (en)
Inventor
모텐센 포맨 마크
Original Assignee
리로이 휘테커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리로이 휘테커, 일라이 릴리 앤드 캄파니 filed Critical 리로이 휘테커
Publication of KR920016088A publication Critical patent/KR920016088A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

내용 없음

Description

하부 요로 질환의 치료
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 토모크세틴 또는 그의 약학적으로 허용되는 염의 하부 요로 질환 치료용 용도.
  2. 토모크세틴 또는 그의 약학적으로 허용되는 염의 요실금 치료용 용도.
  3. 토모크세틴 또는 그의 약학적으로 허용되는 염의 배뇨근 불안정증 치료용 용도.
  4. 토모크세틴 또는 그의 약학적으로 허용되는 염의 간질성 방광염 치료용 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920002706A 1991-02-25 1992-02-22 하부 요로 질환의 치료 KR920016088A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66076791A 1991-02-25 1991-02-25
US07/660,767 1991-02-25

Publications (1)

Publication Number Publication Date
KR920016088A true KR920016088A (ko) 1992-09-24

Family

ID=24650885

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920002706A KR920016088A (ko) 1991-02-25 1992-02-22 하부 요로 질환의 치료

Country Status (12)

Country Link
US (1) US5441985A (ko)
EP (1) EP0501705B1 (ko)
JP (1) JP3222524B2 (ko)
KR (1) KR920016088A (ko)
AT (1) ATE137965T1 (ko)
AU (1) AU642582B2 (ko)
CA (1) CA2061665C (ko)
DE (1) DE69210654T2 (ko)
DK (1) DK0501705T3 (ko)
HU (1) HU215122B (ko)
PH (1) PH30083A (ko)
ZA (1) ZA921292B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US6113876A (en) * 1996-01-29 2000-09-05 Eli Lilly And Company Methods of increasing sphincter competence
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
JP2003503450A (ja) 1999-07-01 2003-01-28 ファルマシア・アンド・アップジョン・カンパニー 高選択的ノルエピネフリン再取込みインヒビターおよびその使用方法
JP4348808B2 (ja) 1999-12-27 2009-10-21 トヨタ紡織株式会社 枠体に対する機能性部材の取付構造
JP4337201B2 (ja) 1999-12-27 2009-09-30 トヨタ紡織株式会社 スプリング構造体の取付構造
AU2002245385B2 (en) * 2001-03-06 2007-01-18 Eli Lilly And Company Inhibitor of monoamine uptake
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
EP2412719A1 (en) 2002-12-02 2012-02-01 Xenome Ltd Chi-conotoxin peptides
ES2383358T3 (es) 2002-12-02 2012-06-20 Xenome Ltd Péptidos de chi-conotoxina que tienen un ácido piroglutámico N-terminal
AU2004227945B2 (en) * 2003-04-04 2006-10-26 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
AU2004312059A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Atomoxetine formulations
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
EP1745029A1 (en) * 2004-04-30 2007-01-24 Warner-Lambert Company LLC Substituted morpholine compounds for the treatment of central nervous system disorders
US20060189698A1 (en) * 2005-02-24 2006-08-24 Check Jerome H Treatment of interstitial cystitis
KR101220803B1 (ko) 2010-12-28 2013-01-11 주식회사 포스코 차량용 시트 구조
DE102013019618A1 (de) * 2013-11-25 2015-05-28 Avlen Georges Tri- und Tetracyclische Verbindungen zur Behandlung von Inkontinenz

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
ZA817863B (en) * 1980-11-14 1983-06-29 Lilly Co Eli (-)n-methyl-3-(2-methylphenoxy)-3-phenylpropylamnie,antidepressant
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
PT87163B (pt) * 1987-04-09 1992-07-31 Lilly Co Eli Processo para a preparacao de 1-fenil-3-naftaleniloxi-propanaminas
SE8804003D0 (sv) * 1988-11-04 1988-11-04 Pharmacia Ab Compounds for the treatment of urinary incontinence

Also Published As

Publication number Publication date
DE69210654T2 (de) 1996-10-24
DE69210654D1 (de) 1996-06-20
HU215122B (hu) 1998-09-28
CA2061665A1 (en) 1992-08-26
PH30083A (en) 1996-12-27
HU9200602D0 (en) 1992-05-28
EP0501705A1 (en) 1992-09-02
AU642582B2 (en) 1993-10-21
ATE137965T1 (de) 1996-06-15
DK0501705T3 (da) 1996-06-03
HUT62192A (en) 1993-04-28
EP0501705B1 (en) 1996-05-15
JPH0570343A (ja) 1993-03-23
AU1117092A (en) 1992-08-27
JP3222524B2 (ja) 2001-10-29
ZA921292B (en) 1993-08-23
CA2061665C (en) 2002-04-16
US5441985A (en) 1995-08-15

Similar Documents

Publication Publication Date Title
KR920016088A (ko) 하부 요로 질환의 치료
KR920019342A (ko) 골질환 치료제
KR950700060A (ko) 운동 뉴우런 질병의 치료에 유용한 약품을 얻기 위한 2-아미노-6-트리플루오로메톡시 벤조티아졸(리루졸)의 사용(Application of 2-amino 6-trifluoromethoxy benzothiazole(riluzole) for obtaining a drug useful in the treatment of motor neuron diseases)
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
ES2124225T3 (es) Tratamiento de la disfuncion erectil.
KR940008686A (ko) 뇨 및 배설 실금(失禁) 치료제 제조용 모다피닐(modafinil)
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
KR940018087A (ko) 진통제 및 소염제로서의 6-클로로-5-플루오로-3-(2-테노일)-2-옥신돌-ⅰ-카복스아미드
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
DE69113466T2 (de) Sulfonanilidderivat und arzneimittel.
KR950701820A (ko) 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
DE69315396D1 (de) Wegwerfwindel
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
FR2674434B1 (fr) Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
KR890003373A (ko) 수면장애 및 우울증 치료에 화합물의 이용
DE69100171T2 (de) Synergistische Kombination zur ophthalmischen Verwendung.
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
KR920009403A (ko) 수면장해 치료용 이미다조벤조디아제핀
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
KR890000089A (ko) 신장 질환 치료제

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E902 Notification of reason for refusal
E601 Decision to refuse application
J201 Request for trial against refusal decision
B601 Maintenance of original decision after re-examination before a trial
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 19991202

Effective date: 20010928

S901 Examination by remand of revocation
E902 Notification of reason for refusal
S601 Decision to reject again after remand of revocation